Transasia Bio-medicals Strengthens Executive Leadership To Fuel Growth

Transasia Bio-Medicals Ltd., India's largest In-vitro Diagnostic (IVD) Company, which is aggressively investing in its vision of becoming one of the top IVD players worldwide focused on emerging markets, today announced the appointment of industry veterans Ravi Kaushik and Bhupendra Chaudhary as Chief Executive Officer and President - Sales and Marketing, respectively. Anil Jotwani, an industry veteran and long-time employee have also been promoted to Senior President - Sales and Marketing. Ravi Kaushik was Group Marketing Director - Asia Pacific & Country Business Director - Diabetes (Indian Sub-continent), Medtronic and Bhupendra Chaudhary was President - Medical Devices & Consumables at Entero Healthcare Solutions, prior. Ravi Kaushik brings 25+ years of experience in strategic sales, marketing plus product & business model innovation across medical devices, pharmaceutical, healthcare, LED lighting, industrial, energy, power and engineering in USA, Europe, Asia Pacific and Indian markets with industry leaders like Baxter, GE Healthcare, GE Lighting and Eaton Corporation. Bhupendra Chaudhary brings over 2 decades of leadership experience across companies like Dr Store Healthcare Services, SRS Meditech/ Sterife and Widex India Pvt. Ltd.

According to Suresh Vazirani, Chairman & Managing Director, Transasia Bio-Medicals Ltd., “As we ready ourselves to emerge as among the top 10 IVD players in the world focused on emerging markets, it was imperative that we strengthened our leadership team further. Ravi and Bhupendra, between them, bring diverse and relevant experience in new product development, strategic planning, business model innovation and regulatory approval among others. Anil has been with us for long and knows the space as none else does. The expanded leadership team now is complete in every sense and look forward to accelerating our progress towards the larger goal.”

Accepting the role, Ravi Kaushik, CEO, Transasia Bio-Medicals, said,” Transasia-Erba group is one of the earliest MedTech innovators launching many new products continuously over the last decade or so in India and emerging markets. The group positively impacts the lives of millions of patients by leveraging innovative local for global technologies to deliver affordable and reliable diagnostic systems. I am honoured to take their legacy forward by combining my experience in healthcare devices with their passionate patient-centric team.”

Anil Jotwani, Sr. President, Sales & Marketing, said, “Am excited to see the industry moving towards being patient-centric with the consumer-friendly offering which is a strong point of Transasia since its inception. Look forward to playing a continued role in driving the team inside towards the company’s larger goals.”

In his comments, Bhupendra Chaudhary, President - Sales and Marketing, said, “I am truly inspired by the transformative potential of Transasia’s products and thrilled at the opportunity to bring these innovations to life.”

Adopting a ‘Customer First’ policy, Transasia’s vast network of more than 40,000 customers supported by more than 300 service engineers, 400+ sales and marketing team, 24 zonal offices, and 350+ distributors reach out to customers across the smallest towns/cities of India in a record response time. With the newly strengthened executive leadership team, Transasia looks forward to its’ continued growth in 100+ countries with soon to be launched exciting new products in cutting-edge technologies like molecular and infectious diseases diagnostics.